Sept. 9, 2026
Weight Watchers announced today that it has appointed Stephen Bye as its President and CEO and a member of the company’s Board of Directors. “Bye’s appointment will become effective this fall. He most recently served as President and CEO of Ookla, a global connectivity intelligence company whose industry leading brands include Speedtest, Downdetector, RootMetrics and Ekahau. During his tenure, Bye transformed and scaled this business, significantly growing the company’s subscription revenue while improving operational efficiency and profitability. He also led the successful integration of multiple acquisitions.”
“We are thrilled to welcome Stephen as the CEO of Weight Watchers,” said Gene Davis, Chairman of the Weight Watchers Board of Directors. “He is a proven chief executive and operations expert with a track record of growing subscription businesses, strengthening consumer offerings and creating significant shareholder value. At Ookla, he redesigned and rebuilt the subscription business, sharpened the company’s product line and go-to-market strategy and drove meaningful growth, significantly increasing the company’s enterprise value during his tenure. That combination of consumer focus, operational discipline and technological expertise makes him exceptionally well suited to lead Weight Watchers through its next phase of growth.”
Commentary
Here we go again…WW hires a CEO with technology expertise but NO track record working in healthcare, wellness or the weight loss market. Why does WW (and other weight loss companies) continue to do this? We question this move. WW is not a cell phone company. It has to deal with women’s health issues, insurance reimbursement, weight loss drugs, healthcare delivery systems such as telehealth and MDs, etc. We don’t believe that Mr. Bye, competent as he may be in terms of tech and operations, knows the nuances and history of the weight loss market. So, he has to go through an education period to get “up to speed”. That could take years. Mr. Bye does not seem to have a deep background in Marketing either.
“Prior to his role at Ookla, he held senior leadership roles across some of the world’s largest communications and technology businesses. He served as Executive Vice President and Chief Commercial Officer of DISH Network’s wireless business, where he helped lead the development and commercialization of the company’s next-generation wireless network. He previously served as CEO of Connectivity Wireless, President of C Spire and Chief Technology Officer of Sprint, where he oversaw the deployment and evolution of the company’s nationwide network. Earlier in his career, he held leadership positions at Cox Communications, AT&T, BellSouth International, Optus Communications and Telstra.”
We say, so what? How does that transfer to a consumer healthcare business?
Learn More About The Commercial & Medical Weight Loss Market – Marketdata LLC Reports
Marketdata LLC’s March 2026 report: “The U.S. Weight Loss Market: Status Report & 2026 Forecast” This 108-page analysis tracks the current status of ALL weight loss market segments, 2025 performance, the latest dieting trends, 15 competitor profiles, with 27 tables and charts.
Some findings:
- The total U.S. weight loss market was worth $135 billion in 2025 (when including the revenues of health clubs ). A 6.6% increase is forecast in 2026, largely due to growing sales of GLP-1 drugs.
- Commercial weight loss companies/centers (Weight Watchers, NutriSystem, jenny Craig, Medifast) saw revenues fall by 24% as a group in 2025, to $1.86 billion, as they struggle to pivot and deal with strong competition from the GLP-1 drugs.
- All medical programs accounted for a new high of 38% of the total market, worth $51.5 billion last year. This is up sharply from 11% in 2022, prior to the GLP-1 drugs boom.
- The number of bariatric surgeries is estimated to have fallen by 8% in 2024 and another 6% in 2025, to 232,000.
- The market for prescription obesity medications is estimated to have increased by 64%, to $43.48 billion. Growth will be slower in 2026, as new and cheaper weight loss pills enter the market.
- Meal replacements and OTC appetite suppressants is a $4.2 billion market. Shakes and nutrition bars have held up well but retail diet pills sales are plummeting.
The complete report is available for sale, for $995, at: marketdataenterprises.com, or by calling Marketdata at: 813-971-8080. A Table of Contents can be found at the website.
Note: Marketdata’s specialty for 37 years since 1989 has been the weight loss market, with 50+ published in-depth studies, custom research projects and consulting.
The report includes in-depth analyses of: 2024-2025 market/revenue performance, recent competitor and market developments, current dieter trends and top diet plans, and diet company advertising and marketing spending. Special emphasis and analysis of the obesity drugs market and its effect on all market segments. Coverage of cheaper compounded drugs that are not FDA-approved, new drugs entering the market.
Individual Status Reports and the effects of the obesity drugs boom on operations and revenues, for ALL major weight loss market segments… diet soft drinks, artificial sweeteners, health clubs industry, commercial weight loss chains, retail meal replacements and appetite suppressants, and low-calorie dinner entrees.
Includes profiles and 2025 performance of: Medifast, Weight Watchers, NutriSystem, Slim-Fast, Simply Good Foods (Atkins) Herbalife, AMWAY, Premier Protein, Eli Lillky, Novo Nordisk and Noom.
Buy This Report: Call 813-971-8080 and charge it or order online for instant download at: www.marketdataenterprises.com.